Uroplasty, Inc. (UPI) Tops Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts UPI Hot Sheet
Join SI Premium – FREE
Uroplasty, Inc. (NASDAQ: UPI) reported Q2 EPS of ($0.06), $0.02 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $5 million versus the consensus estimate of $4.93 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Avnet (AVT) Tops Q4 EPS by 61c; offers guidance
- Orthofix International (OFIX) Tops Q2 EPS by 1c; Offers Guidance
- BioCryst Pharma (BCRX) Tops Q2 EPS by 14c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
